The Supply Chain refers to the entire network of entities, resources, activities, and technologies involved in the creation and sale of a product, from the sourcing of starting materials from the supplier to the manufacturer, through to its eventual delivery to the end user. Just-in-time has been, for a long time, the most successful supply chain model for maximizing efficiency. But, currently, it’s no longer the best.

International business platform in the pharmaceutical sector. CPhI Japan is Japan's most comprehensive pharma event, which brings together more than 26,000 pharma industry professionals from 60 countries.

CPhI Americas bringing together end-to-end pharma from across the Americas...

Angelini Pharma has been awarded the prestigious Top Employer certification for the sixth consecutive year. 

Digitalization in the pharmaceutical industry refers to the integration and adoption of digital technologies to fundamentally change how companies operate, deliver value, and interact with stakeholders. It goes beyond individual technology implementations and is related to a re-design of business processes, organizational culture, and customer experiences.

BOS Basel 2025's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics and also covering Novel Therapeutic Entities.

Chemspec Europe showcases the entire spectrum of fine and speciality chemicals for various applications and industries.

Sustainability has been a frequently mentioned concept over the last few years across many manufacturing platforms but more recently has become a popular topic within the pharmaceutical industry.

As generic competition increases it is crucial to examine different ways to improve efficiency and cost reduction in the manufacturing process for the active pharmaceutical ingredient (API).

The active pharmaceutical ingredient (API) is the foundation of a final drug product and is a crucial consideration when choosing a Contract Development and Manufacturing Organisation (CDMO) or Contract Research (in House) Development and Manufacturing Organisation (CRDMO).

Drugs & APIs shortage is a global issue with an evident impact affecting all the people independently of their geographic or economic position.

Over the past 10+ years the pharmaceutical Industry has utilized CDMO’s at an increasing level from year to year never seen prior to this period...

Today CDMOs face excellent growth opportunities in a pharmaceutical market environment where using  outsourcing services is becoming the new norm...

Facing the rising number of custom HPAPIs demand, Angelini Fine Chemicals decided to expand its HPAPI capacity at its Aprilia,Italy plant site

The continuous-flow enantioselective processes have to be seen as a pivot point for sustainable development of the tomorrow’s pharmaceutical industry

Today Contract Development Manufacturing Organizations (CDMOs) face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm